MedPath

BEXAROTENO CIPLA 75 MG CAPSULAS BLANDAS EFG

BEXAROTENO CIPLA 75 MG CAPSULAS BLANDAS EFG

Commercialized
Register Number

86479

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Dec 28, 2021

Dosage Form

CÁPSULA BLANDA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number86479
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BEXAROTENOActive
Quantity: 75 mg
Name: BEXAROTENO

ATC CLASSIFICATION (3)

L01X
L01XF
L01XF03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.